Home

Revance Therapeutics, Inc. - Common Stock (RVNC)

3.6300
0.00 (0.00%)

Revance Therapeutics is a biotechnology company focused on developing innovative therapies for various medical conditions, primarily in the fields of aesthetics, neuromodulation, and pain management

The company specializes in creating advanced drug formulations and delivery technologies that aim to provide longer-lasting effects and improve patient outcomes. Through its proprietary products, Revance aims to address unmet medical needs while enhancing the quality of life for patients. The company's portfolio includes both aesthetic treatments and therapeutic applications, showcasing its commitment to innovation in the healthcare sector.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Revance Therapeutics, Inc. - Common Stock publicly traded?
Yes, Revance Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Revance Therapeutics, Inc. - Common Stock trade on?
Revance Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revance Therapeutics, Inc. - Common Stock?
The ticker symbol for Revance Therapeutics, Inc. - Common Stock is RVNC on the Nasdaq Stock Market
What is the current price of Revance Therapeutics, Inc. - Common Stock?
The current price of Revance Therapeutics, Inc. - Common Stock is 3.630
When was Revance Therapeutics, Inc. - Common Stock last traded?
The last trade of Revance Therapeutics, Inc. - Common Stock was at 9:36 am EST on January 31st, 2025
What is the market capitalization of Revance Therapeutics, Inc. - Common Stock?
The market capitalization of Revance Therapeutics, Inc. - Common Stock is 260.74M
How many shares of Revance Therapeutics, Inc. - Common Stock are outstanding?
Revance Therapeutics, Inc. - Common Stock has 71.83M shares outstanding.